Hair fall and thinning are universal concerns. Dermatology often treats them with drugs like Minoxidil and Finasteride. Although these are effective, they come with unwanted side effects — depression, sexual dysfunction, chest tightness, and more — so the global market has developed many active ingredients to replace them without those drawbacks. Capixyl is one such active that reduces hair fall, addresses thinning, and stimulates new growth.
What is Capixyl?
Capixyl Capixyl is an active ingredient combining Red Clover Extract (rich in Biochanin A) with Acetyl Tetrapeptide-3. This bioactive duo not only reduces hair fall but also stimulates new growth, making it a popular ingredient in scalp and hair-care products. It's so gentle and safe that it's even used in eyelash-care products.
How does Capixyl reduce hair fall?
Capixyl reduces hair fall and stimulates new growth through three main mechanisms:
- Addresses DHT-driven hair fall
- Biochanin A in red clover acts as a 5α-reductase inhibitor, blocking both Type 1 and Type 2 of the enzyme that converts testosterone into DHT — the hormone behind hair fall.
- An ex vivo lab test found that Biochanin A reduces 5α-reductase Type 1 by 64% and Type 2 by as much as 93%.
- Boosts stem-cell activity at the hair root (Dermal Papilla)
- Acetyl Tetrapeptide-3 in Capixyl helps reduce hair fall by strengthening hair and improving its anchorage to the scalp, while stimulating new growth by activating stem cells at the dermal papilla.
- An ex vivo lab test found that follicle cells in the Anagen (growth) phase treated with Capixyl for 11 days grew 87% longer compared with untreated follicles — meaning Capixyl-treated hair is stronger than hair receiving no nourishment.
- Reduces inflammation — another cause of hair loss
- Capixyl also reduces inflammation in fibroblast cells — the cells that build and maintain the extracellular matrix (ECM) and collagen. Inflammation in these cells is another contributor to hair fall.
- An ex vivo lab test found that follicle cells in the Anagen (growth) phase treated with Capixyl for 11 days grew 87% longer compared with untreated follicles — meaning Capixyl-treated hair is stronger than hair receiving no nourishment.
Capixyl vs Minoxidil — head-to-head efficacy
An ex vivo test comparing Minoxidil and Capixyl on follicles collected during the Anagen (growth) phase over 7 days found that follicles treated with Minoxidil grew 52% longer, while follicles treated with Capixyl grew 156% — three times more than Minoxidil.
'3× more than Minoxidil'
Capixyl clinical-trial results
In a 4-month clinical trial of 30 volunteers — 15 treated with Capixyl and 15 with placebo — the results showed:
Hair in the Anagen (growth) phase increased by 13% over 4 months for Capixyl users
Hair in the Telogen (shedding) phase decreased by 29% over 4 months for Capixyl users
These clinical results mean that Capixyl raises the share of hairs in the growth phase while reducing those entering the resting or shedding phase — yielding visibly thicker hair and noticeably less shedding.
How to choose a product containing Capixyl
To see results from a Capixyl-containing product — for hair fall, thinning, inflammation, or new growth — the manufacturer recommends concentrations of 0.5%–2.5% for preventive care and 2.5%–5% for intensive treatment.
AloEx uses premium Capixyl imported from Canada at a 3% concentration — at the upper end of the intensive-treatment range. This delivers every benefit Capixyl is designed for: reducing genetic hair fall driven by DHT, reducing hair fall from scalp inflammation, improving hair anchorage to the scalp, and boosting stem-cell activity at the follicle for strong, effective new growth.
